查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1772250

骨科生物學市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測，2025 年至 2033 年

Orthobiologics Market Size, Share & Trends Analysis Report By Product (DBM, Allograft, BMP, Viscosupplementation), By Application (Spinal Fusion, Trauma Repair), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

骨科生物學市場的成長和趨勢

根據Grand View Research, Inc.的最新報告，全球骨科生技藥品市場規模預計到2033年將達到103.4億美元，2025年至2033年期間的複合年成長率為4.74%。

全球整形外科手術病例的增加推動了對骨科生技藥品的需求。美國整形外科學會 (AAOS) 2023 年年會上發布的一項研究表明，骨科醫生將面臨挑戰，難以滿足日益成長的全置換術(TJA) 需求。研究表明，為了滿足需求，外科醫生需要每五年將 TJA 手術病例數量加倍，或將外科醫生數量增加 10%。

隨著對醫療保健進步和患者療效的日益關注，世界各國政府正在實施政策和舉措，以促進骨科生技藥品的發展。例如，美國整形外科學會 (AAOS) 致力於以透明、科學的方式改善肌肉骨骼護理。 2020 年 10 月，AAOS 在其網站上推出了生技藥品儀表板，幫助骨科外科醫生了解生技藥品治療方法的核准情況。該舉措是 AAOS 生物製劑計劃的一部分，該計劃為肌肉骨骼健康界提供實證指導。作為這項工作的一部分，AAOS 董事會還修訂了兩份與生技藥品相關的立場聲明：

全球老齡人口的成長也有望推動整形外科手術的需求。根據《2023年印度老化報告》，印度老齡人口正快速成長，十年成長率高達41%。到2050年，預計印度老齡人口將超過20%。隨著年齡的成長，人們更容易出現肌肉和骨骼問題，包括骨質疏鬆症、骨關節炎和骨折。這將導致對骨科生技藥品的需求增加。

此外，預計道路案例數量的增加將促進市場成長。根據美國公路交通安全管理局 (NHTSA) 的報告， 第一季。因此，受傷人數的增加預計將增加對骨科生技藥品的需求。

該市場的主要企業正致力於擴大其產品供應和覆蓋範圍，並採用聯盟、供應協議和夥伴關係關係等策略。例如，2023年9月，HippoFi Inc. 與 Zimmer Biomet Holdings Inc. 合作推出了一種用於骨骼生長的合成生物材料。該生物材料預計將於2024年由 HippoFi 的生技藥品子公司 PUR Biologics 上市。

生技藥品市場亮點

  • 根據產品情況，關節內粘稠補充療法領域在 2024 年佔據了骨科生物製品市場的主導地位，佔據了 42.21% 的最大收入佔有率，這歸因於文明病的患病率不斷上升以及透明質酸療法的進步。
  • 根據應用情況，由於椎間盤退化性疾病的盛行率不斷上升，脊椎融合手術領域將在 2024 年佔據最大的收益佔有率，超過 48.29%。
  • 根據最終用途，由於接受外科手術的患者數量增加，醫院部門在生技藥品行業佔據主導地位，到 2024 年收益佔有率將超過 75%。
  • 2024 年，北美佔據骨科生物技術市場的主導地位，佔據最大的收益佔有率，為 46.03%。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章 骨科生物學市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 骨科生物學：市場分析工具
    • 產業分析—波特五力分析
    • PESTLE分析
  • 法律規範
  • 整形外科疾病盛行率
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 整形外科產業主要相關人員的舉措
  • 整形外科產業資金籌措市場
    • 10整形外科公司將於 2024 年第一季完成新一輪資金籌措
    • 資金籌措公告

4. 骨科生物學市場區隔分析（依產品），2021 年至 2033 年

  • 定義和範圍
  • 2021年及2033年產品市場佔有率分析
  • 細分儀表板
  • 2021 年至 2033 年全球骨科生物製品市場（按產品）
  • 去礦物質骨基質（DBM）
    • 去礦物質骨基質（DBM）市場預測及預測（2021-2033）
  • 同種異體移植
    • 同種異體移植市場規模估計及預測（2021-2033年）
  • 骨形成蛋白（BMP）
    • 骨形成蛋白（BMP）市場預測與預測（2021-2033）
  • 關節內粘稠補充療法
    • 關節內粘稠補充療法市場評估及預測（2021-2033 年）
  • 合成骨替代物
    • 2021-2033年合成骨替代品市場規模預測
  • 幹細胞療法
    • 幹細胞治療市場估計與預測（2021-2033）

5. 骨科生物學市場細分分析（按應用），2021 年至 2033 年

  • 定義和範圍
  • 2021 年和 2033 年應用市場佔有率分析
  • 細分儀表板
  • 2021-2033 年全球骨科生物製劑市場（依應用）
  • 脊椎融合
    • 2021-2033年脊椎融合市場預測及預測
  • 創傷修復
    • 2021-2033年創傷修復市場估計與預測
  • 重組手術
    • 2021-2033年重組外科市場估計與預測

6. 骨科生物學市場細分分析（依最終用途），2021 年至 2033 年

  • 定義和範圍
  • 2021年及2033年最終用途市場佔有率分析
  • 細分儀表板
  • 2021 年至 2033 年全球骨科生物製劑市場（依最終用途分類）
  • 醫院
    • 2021-2033年醫院市場估計與預測
  • 整形外科診所
    • 2021-2033年整形外科診所市場估計與預測

7. 骨科生物學市場細分分析（按地區、產品、應用和最終用途），2021 年至 2033 年

  • 2021 年及 2033 年區域市場佔有率分析
  • 區域市場儀表板
  • 區域市場概況
  • 2021 年及 2033 年骨科生物製品各地區市場佔有率
  • 北美洲
    • 2021-2033 年北美骨科生物製劑市場
    • 美國
    • 加拿大
  • 歐洲
    • 2021-2033年歐洲骨科生物製劑市場
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司簡介
    • Medtronic Plc
    • DePuy Synthes
    • Zimmer Biomet
    • Stryker Corporation
    • Bioventus LLC
    • Seaspine Holdings Corporation
    • Orthofix, Inc.
    • Globus Medical
    • Arthrex, Inc.
    • Bone Biologics Corp.
Product Code: GVR-1-68038-360-7

Orthobiologics Market Growth & Trends:

The global orthobiologics market size is estimated to reach USD 10.34 billion by 2033, expanding at a CAGR of 4.74% from 2025 to 2033, according to a new report by Grand View Research, Inc. Increasing cases of orthopedic surgeries across the globe is driving the demand for orthobiologics. A study presented at the Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS) 2023, revealed that orthopedic surgeons would face a challenge in meeting the increasing demand for total joint arthroplasty (TJA). The study found that to keep up with the demand, surgeons will have to either double their TJA caseload or increase the number of surgeons by 10% every five years.

With an increasing focus on healthcare advancements and patient outcomes, governments worldwide are implementing policies and initiatives to foster the growth of orthobiologics. For instance, the American Academy of Orthopedic Surgeons (AAOS) is committed to improving musculoskeletal care in a transparent and scientific way. In October 2020, the AAOS launched the Biologics Dashboard on their website, which is designed to assist orthopedic surgeons in keeping track of the approval status of biologic-based interventions. This initiative is a part of the AAOS Biologics Initiative, which offers evidence-based guidance to the musculoskeletal health community. As part of this effort, the AAOS Board of Directors also revised two position statements related to biologics.

Increasing geriatric population across the globe is also anticipated to boost the demand for orthopedic surgeries. According to the India Ageing Report 2023, country's elderly population is growing at a rapid pace, with a decadal growth rate of 41%. By 2050, over 20% of India's population will be elderly citizens.As people age, they are more likely to experience issues with their muscles and bones, such as osteoporosis, osteoarthritis, and fractures. This results in a greater need for orthobiologics solutions.

Moreover, increasing cases of road accidents is anticipated to supplement the market growth. According to the National Highway Traffic Safety Administration report, there were an estimated 19,515 deaths in motor vehicle accidents during the first half of 2023. This represents a decrease of about 3.3% compared to the same period in the previous year, which had 20,190 fatalities. The report also shows that fatalities decreased during both the first and second quarters of 2023. Thus, the increasing number of injured populations is expected to increase the demand for orthobiologics.

The major players operating in the market are adopting strategies such as collaborations, supply agreements, and partnerships with a major focus on enhancing the product formation and reach. For instance, inSeptember 2023, HippoFi Inc. partnered with Zimmer Biomet Holdings Inc. to bring forth a synthetic biomaterial for bone growth. The biomaterial will be launched under HippoFi's biologic subsidiary, PUR Biologics in 2024.

Orthobiologics Market Report Highlights:

  • Based on product, the viscosupplementation segment dominated the orthobiologics market in 2024 and accounted for the largest revenue share of 42.21% owing to the increasing prevalence of lifestyle-related conditions and advances in hyaluronic acid therapy development
  • Based on application, the spinal fusion segment held the largest revenue share of over 48.29% in 2024 owing to the rising incidence of degenerative disc disease
  • Based on end-use, the hospitals segment dominated the orthobiologics industry in 2024 with a revenue share of over 75% due to the growing patient population undergoing surgical procedures
  • North America dominated the orthobiologics market in 2024 and accounted for the largest revenue share of 46.03%

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Orthobiologics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing number of sports injuries and road traffic accidents
      • 3.2.1.2. Increasing adoption of minimally invasive treatments
      • 3.2.1.3. Increasing reimbursement coverage for orthopedic procedures
      • 3.2.1.4. Growing aging population and increase in chronic diseases
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Availability of alternative treatments
      • 3.2.2.2. Stringent regulatory framework
  • 3.3. Orthobiologics: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Regulatory Framework
  • 3.5. Orthopedic Disease Prevalence
    • 3.5.1. North America
    • 3.5.2. Europe
    • 3.5.3. Asia Pacific
    • 3.5.4. Latin America
    • 3.5.5. Middle East and Africa
  • 3.6. Initiatives by key stakeholders in the Orthopedic Industry
  • 3.7. Orthopedic Industry Funding Market
    • 3.7.1. 10 Orthopedic Companies Close New Funding Rounds in 1Q24 Funding
    • 3.7.2. Funding Announcements

Chapter 4. Orthobiologics Market Segment Analysis, By Product, 2021-2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Product Type Market Share Analysis, 2021 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Orthobiologics Market, by Product Type, 2021 to 2033
  • 4.5. Demineralized Bone Matrix (DBM)
    • 4.5.1. Demineralized Bone Matrix (DBM) market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Allograft
    • 4.6.1. Allograft market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7. Bone morphogenetic protein (BMP)
    • 4.7.1. Bone morphogenetic protein (BMP) market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.8. Viscosupplementation
    • 4.8.1. Viscosupplementation market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.9. Synthetic bone substitutes
    • 4.9.1. Synthetic bone substitutes market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.10. Stem cell therapy
    • 4.10.1. Stem cell therapy market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Orthobiologics Market Segment Analysis, By Application, 2021-2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2021 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global orthobiologics Market, by Application, 2021 to 2033
  • 5.5. Spinal Fusion
    • 5.5.1. Spinal fusion market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Trauma repair
    • 5.6.1. Trauma repair market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. Reconstructive surgery
    • 5.7.1. Reconstructive surgery market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Orthobiologics Market Segment Analysis, By End Use, 2021-2033 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share Analysis, 2021 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Global Orthobiologics Market, by end use, 2021 to 2033
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Orthopedic Clinics
    • 6.6.1. Orthopedic Clinics market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Orthobiologics Market Segment Analysis, By Region, By Product, By Application, By End Use, 2021- 2033 (USD Million)

  • 7.1. Regional Market Share Analysis, 2021 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Orthobiologics Market Share by Region, 2021 & 2033:
  • 7.5. North America
    • 7.5.1. North America orthobiologics market, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. U.S. orthobiologics market, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Canada orthobiologics market, 2021 - 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe orthobiologics market, 2021 - 2033 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. UK orthobiologics market, 2021 - 2033 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Germany orthobiologics market, 2021 - 2033 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. France orthobiologics market, 2021 - 2033 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Italy orthobiologics market, 2021 - 2033 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Spain orthobiologics market, 2021 - 2033 (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Norway orthobiologics market, 2021 - 2033 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Sweden orthobiologics market, 2021 - 2033 (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Denmark orthobiologics market, 2021 - 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Japan orthobiologics market, 2021 - 2033 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. China orthobiologics market, 2021 - 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. India orthobiologics market, 2021 - 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Australia orthobiologics market, 2021 - 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. South Korea orthobiologics market, 2021 - 2033 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Thailand orthobiologics market, 2021 - 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Brazil orthobiologics market, 2021 - 2033 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Mexico orthobiologics market, 2021 - 2033 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Argentina orthobiologics market, 2021 - 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. South Africa orthobiologics market, 2021 - 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Saudi Arabia orthobiologics market, 2021 - 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. UAE orthobiologics market, 2021 - 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Kuwait orthobiologics market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Profiles
    • 8.3.1. Medtronic Plc
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. DePuy Synthes
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Zimmer Biomet
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Stryker Corporation
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bioventus LLC
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Seaspine Holdings Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Orthofix, Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Globus Medical
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Arthrex, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Bone Biologics Corp.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global orthobiologics market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 5 Global orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 6 Global orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 7 North America orthobiologics market, by region, 2021 - 2033 (USD Million)
  • Table 8 North America orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 9 North America orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 10 North America orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 11 U.S. orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 12 U.S. orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 13 U.S. orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 14 Canada orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 15 Canada orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 16 Canada orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 17 Europe orthobiologics market, by region, 2021 - 2033 (USD Million)
  • Table 18 Europe orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 19 Europe orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 20 Europe orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 21 Germany orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 22 Germany orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 23 Germany orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 24 UK orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 25 UK orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 26 UK orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 27 France orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 28 France orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 29 France orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 30 Italy orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 31 Italy orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 32 Italy orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 33 Spain orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 34 Spain orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 35 Spain orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 36 Denmark orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 37 Denmark orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 38 Denmark orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 39 Sweden orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 40 Sweden orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 41 Sweden orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 42 Norway orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 43 Norway orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 44 Norway orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific orthobiologics market, by region, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 49 China orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 50 China orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 51 China orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 52 Japan orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 53 Japan orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 54 Japan orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 55 India orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 56 India orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 57 India orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 58 South Korea orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 59 South Korea orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 60 South Korea orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Australia orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 62 Australia orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 63 Australia orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 64 Thailand orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 65 Thailand Orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 66 Thailand Orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 67 Latin America orthobiologics market, by region, 2021 - 2033 (USD Million)
  • Table 68 Latin America orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 69 Latin America orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 70 Latin America orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 71 Brazil orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 72 Brazil orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 73 Brazil orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 74 Mexico orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 75 Mexico orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 76 Mexico orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 77 Argentina orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 78 Argentina orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 79 Argentina orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 80 MEA orthobiologics market, by region, 2021 - 2033 (USD Million)
  • Table 81 MEA orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 82 MEA orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 83 MEA orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 84 South Africa orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 85 South Africa orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 86 South Africa orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 90 UAE orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 91 UAE orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 92 UAE orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 93 Kuwait orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 94 Kuwait orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 95 Kuwait orthobiologics market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Orthobiologics market: outlook
  • Fig. 9 Orthobiologics competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Orthobiologics market driver impact
  • Fig. 12 Orthobiologics market restraint impact
  • Fig. 13 Porter's Analysis
  • Fig. 14 PESTLE Analysis
  • Fig. 15 Orthobiologics market: Product movement analysis
  • Fig. 16 Orthobiologics market: Product outlook and key takeaways
  • Fig. 17 Demineralized bone matrix (DBM) market estimates and forecast, 2021 - 2033
  • Fig. 18 Allograft estimates and forecast, 2021 - 2033
  • Fig. 19 Bone morphogenetic protein (BMP) estimates and forecast, 2021 - 2033
  • Fig. 20 Viscosupplementation estimates and forecast, 2021 - 2033
  • Fig. 21 Synthetic bone substitutes estimates and forecast, 2021 - 2033
  • Fig. 22 Stem cell therapy estimates and forecast, 2021 - 2033
  • Fig. 23 Orthobiologics Market: Application Movement Analysis
  • Fig. 24 Orthobiologics market: Application outlook and key takeaways
  • Fig. 25 Spinal fusion market estimates and forecasts, 2021 - 2033
  • Fig. 26 Trauma repair market estimates and forecasts, 2021 - 2033
  • Fig. 27 Reconstructive surgery market estimates and forecasts, 2021 - 2033
  • Fig. 28 Orthobiologics market: End use movement analysis
  • Fig. 29 Orthobiologics market: End use outlook and key takeaways
  • Fig. 30 Hospitals market estimates and forecasts, 2021 - 2033
  • Fig. 31 Orthopedic Clinics market estimates and forecasts, 2021 - 2033
  • Fig. 32 Global orthobiologics market: Regional movement analysis
  • Fig. 33 Global orthobiologics market: Regional outlook and key takeaways
  • Fig. 34 North America orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 35 Key country dynamics
  • Fig. 36 U.S. orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Canada orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 39 Europe orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Spain orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 46 Key country dynamics
  • Fig. 47 France orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Italy orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Norway orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Denmark orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Sweden orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 56 Asia Pacific orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Japan orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 59 Key country dynamics
  • Fig. 60 China orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 61 Key country dynamics
  • Fig. 62 India orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 65 Key country dynamics
  • Fig. 66 South Korea orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Thailand orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 69 Latin America orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Brazil orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Mexico orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Argentina orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 76 MEA orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 77 Key country dynamics
  • Fig. 78 South Africa orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Saudi Arabia orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 81 Key country dynamics
  • Fig. 82 UAE orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Kuwait orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 85 Key company categorization
  • Fig. 86 Heat map analysis, 2021 - 2033